Concentration-time profile for perhexiline and hydroxyperhexiline in patients at steady state

about

Concentration-time profile for perhexiline and hydroxyperhexiline in patients at steady state

Item

http://www.wikidata.org/entity/Q35825990

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Concentration-time profile for ...... ne in patients at steady state

@ast

Concentration-time profile for ...... ne in patients at steady state

@en

type

Item

label

Concentration-time profile for ...... ne in patients at steady state

@ast

Concentration-time profile for ...... ne in patients at steady state

@en

prefLabel

Concentration-time profile for ...... ne in patients at steady state

@ast

Concentration-time profile for ...... ne in patients at steady state

@en

P1476

Concentration-time profile for ...... ne in patients at steady state

@en

P2093

John D Horowitz

http://www.w3.org/2001/XMLSchema#string

Raymond G Morris

http://www.w3.org/2001/XMLSchema#string

Terry E Jones

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacokinetics of perhexiline maleate in anginal patients with and without peripheral neuropathy

Impaired oxidation of debrisoquine in patients with perhexiline neuropathy

Polymorphic hydroxylation of perhexiline maleate in man.

The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes

Update: clinically significant cytochrome P-450 drug interactions.

Impaired oxidation of debrisoquine in patients with perhexiline liver injury

Efficacy and safety of perhexiline maleate in refractory angina. A double-blind placebo-controlled clinical trial of a novel antianginal agent.

Pharmacokinetics of the antianginal agent perhexiline: relationship between metabolic ratio and steady-state dose.

Relationship between plasma perhexiline concentration and symptomatic status during short-term perhexiline therapy.

Perhexiline toxicity related to citalopram use.

P304

263-269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2125.2003.02003.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8680320

http://www.w3.org/2001/XMLSchema#string

P698

14998422

http://www.w3.org/2001/XMLSchema#string

P932

1884455

http://www.w3.org/2001/XMLSchema#string